Detalhe da pesquisa
1.
Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer.
J Urol;
197(3 Pt 1): 676-683, 2017 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27746282
2.
Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
Eur J Nucl Med Mol Imaging;
43(10): 1773-83, 2016 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27091135
3.
Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance.
J Nucl Med;
62(8): 1089-1096, 2021 08 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33517323
4.
Best Practices for 18F-Fluciclovine PET/CT Imaging of Recurrent Prostate Cancer: A Guide for Technologists.
J Nucl Med Technol;
47(4): 282-287, 2019 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31182661
5.
18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer.
J Nucl Med;
60(11): 1531-1536, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30954940
6.
Change in Salvage Radiotherapy Management Based on Guidance With FACBC (Fluciclovine) PET/CT in Postprostatectomy Recurrent Prostate Cancer.
Clin Nucl Med;
42(1): e22-e28, 2017 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27749412
7.
Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study.
J Nucl Med;
57(9): 1357-63, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27056619